HIGHLIGHTS
- who: Shihan Wang and colleagues from the Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Beijing, China have published the Article: Medium- and Long-Term Effects of Dapagliflozin on Serum Uric Acid Level in Patients with Type 2 Diabetes: A Real-World Study, in the Journal: (JOURNAL)
- what: The authors aimed to explore the and long-term (u226512 weeks) effects of dapagliflozin on serum uric acid (SUA) level in patients with type 2 diabetes mellitus (T2DM) in the real world study and to explore the influencing factors of dapagliflozin on reducing SUA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.